Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Oncogene

• Publication date

  2016-03-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2015.181PMID 26028024
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands

  2014cited by this paper
• A genomic view of mosaicism and human disease

  2013cited by this paper
• A germline mosaic BRCA1 exon deletion in a woman with bilateral basal‐like breast cancer

  2013cited by this paper
• Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model

  2013cited by this paper
• Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

  2013cited by this paper
• A new scoring system in cancer genetics: application to criteria for BRCA1 and BRCA2 mutation screening

  2013cited by this paper
• Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing

  2012cited by this paper
• Retinoblastoma: An Update on Clinical, Genetic Counseling, Epidemiology and Molecular Tumor Biology

  2012cited by this paper
• De novo mutations in human genetic disease

  2012cited by this paper
• A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer

  2011cited by this paper
• EMMA, a cost‐ and time‐effective diagnostic method for simultaneous detection of point mutations and large‐scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients

  2011cited by this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

  2011cited by this paper
• Variation in the mutation rate across mammalian genomes

  2011cited by this paper
• A de novo complete BRCA1 gene deletion identified in a Spanish woman with early bilateral breast cancer

  2011cited by this paper
• Assessment of the prevalence of de novo mutations in the BRCA1 and BRCA2 genes

  2011cited by this paper
• Fertility in women with BRCA mutations: a case-control study.

  2010cited by this paper
• Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

  2010cited by this paper
• A novel de novo BRCA2 mutation of paternal origin identified in a Spanish woman with early onset bilateral breast cancer

  2010cited by this paper
• Case report: de novo BRCA2 gene mutation in a 35‐year‐old woman with breast cancer

  2009cited by this paper
• Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer

  2009cited by this paper
• Impact of BRCA mutations on female fertility and offspring sex ratio

  2009cited by this paper
• Novel de novo BRCA2 mutation in a patient with a family history of breast cancer

  2008cited by this paper
• High‐resolution oligonucleotide array‐CGH applied to the detection and characterization of large rearrangements in the hereditary breast cancer gene BRCA1

  2007cited by this paper
• Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers

  2006cited by this paper
• Models of genetic susceptibility to breast cancer

  2006cited by this paper
• A genome wide scan for familial high myopia suggests a novel locus on chromosome 7q36

  2002cited by this paper
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• De novo mutations in familial adenomatous polyposis (FAP)

  2002cited by this paper
• De novo recurrent germline mutation of theBRCA2 gene in a patient with early onset breast cancer

  2001cited by this paper
• De novo BRCA1 mutation in a patient with breast cancer and an inherited BRCA2 mutation.

  1999cited by this paper
• Identification of the breast cancer susceptibility gene BRCA2

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper

• Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies

  2025influential citation
• Case Report: Functional validation of a rare variant BRCA1 c.5193 + 2dupT in a family with cancer history

  2025cites this paper
• Novel De Novo BRCA2 Variant in an Early-Onset Ovarian Cancer Reveals a Unique Tumor Evolution Pathway

  2025cites this paper
• Case report: Deciphering the clinical significance of a novel partial BRCA1 exon 10 duplication in a patient with triple-negative breast cancer

  2025cites this paper
• Mosaicism in genetic tumour syndromes

  2025cites this paper
• Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.

  2024cites this paper
• Multiple primary synchronous tumors: features of modern diagnosis and treatment

  2024cites this paper
• Contrôle des naissances, stérilité, infertilité : préservation de la fertilité féminine

  2024cites this paper
• Control de la natalidad, esterilidad, infertilidad: preservación de la fertilidad femenina

  2024cites this paper
• A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis

  2024cites this paper
• Breast Cancer Screening and Prophylactic Mastectomy for High-Risk Women in Romania

  2024cites this paper
• Optimal Genetic Testing of Families

  2023cites this paper
• Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?

  2023cites this paper
• Double Heterozygosity for Rare Deleterious Variants in the BRCA1 and BRCA2 Genes in a Hungarian Patient with Breast Cancer

  2023cites this paper
• De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?

  2023cites this paper
• Does a proactive procedure lead to a higher uptake of predictive testing in families with a pathogenic BRCA1/BRCA2 variant? A family cancer clinic evaluation

  2023cites this paper
• A de Novo BRCA1 Pathogenic Variant in a 29-Year-Old Woman with Triple-Negative Breast Cancer

  2023influential citation
• A New de novo BRCA1 Mutation in a Young Breast Cancer Patient: A Case Report

  2023cites this paper
• Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2

  2023influential citation
• Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers.

  2023cites this paper
• Genetic Networks of Alzheimer’s Disease, Aging, and Longevity in Humans

  2023cites this paper
• Low-level constitutional mosaicism of BRCA1 in two women with young onset ovarian cancer

  2022influential citation
• Risk Prediction of Second Primary Malignancies in Primary Early-Stage Ovarian Cancer Survivors: A SEER-Based National Population-Based Cohort Study

  2022cites this paper
• BRCA2 deficiency increases sensitivity of medulloblastoma to Olaparib by inhibiting RAD51-mediated DNA damage repair system

  2022cites this paper
• Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1/2 mutations.

  2021cites this paper
• Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.

  2021cites this paper
• Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients

  2020influential citation
• Evaluation of Vitamin D-Binding Protein Gene Polymorphism and its Plasma Concentration in Kurdish Patients With Breast Cancer in Sanandaj, Iran

  2020cites this paper
• Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes

  2020cites this paper
• The uptake of predictive DNA testing in 40 families with a pathogenic BRCA1/BRCA2 variant. An evaluation of the proband-mediated procedure

  2020cites this paper
• Population-based genetic testing for Women's cancer prevention.

  2020cites this paper
• The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer

  2020cites this paper
• Spectrum of BRCA1/BRCA2 variants in 1419 Turkish breast and ovarian cancer patients: a single center study

  2019cites this paper
• De Novo BRCA1 Pathogenic Variant in a Woman with Breast Cancer at Age 33: A Case Report

  2019cites this paper
• A Pediatric Case of Transformed Mycosis Fungoides in a BRCA2 Positive Patient

  2019cites this paper
• Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients.

  2019cites this paper
• De novo pathogenic germline variant in PALB2 in a patient with pancreatic cancer

  2019cites this paper
• Somatic mutation panels: Time to clear their names.

  2019cites this paper
• Hierarchical core decomposition of RING structure as a method to capture novel functional residues within RING-type E3 ligases: a structural systems biology approach

  2018cites this paper
• The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice

  2018cites this paper
• A case report

  2017cites this paper
• Mutation Frequencies in Patients With Early-Onset Colorectal Cancer.

  2017cites this paper
• A new case of “de novo” BRCA1 mutation in a patient with early‐onset breast cancer

  2017cites this paper
• Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis

  2017cites this paper
• Les défis du séquençage à haut débit dans l'exploration génétique des cancers du sein et de l'ovaire.

  2017cites this paper
• Preservación de la fertilidad femenina

  2017cites this paper
• Analysis of BRCA1 /2 Mutations and Performance of Manchester Scoring System in High Risk Iranian Breast Cancer Patients: A Pilot Study

  2017cites this paper
• Vitamin D, Its Receptor Gene Polymorphism and Breast Cancer

  2017cites this paper
• Mutation Frequencies in Patients With Early-Onset Colorectal Cancer.

  2017cites this paper
• The first case report of a large deletion of the BRCA1 gene in Croatia

  2017cites this paper
• [Fertility preservation in women of the childbearing age: Indications and strategies].

  2016cites this paper
• New insights into the generation and role of de novo mutations in health and disease

  2016cites this paper
• Aggregate penetrance of genomic variants for actionable disorders in European and African Americans

  2016cites this paper
• Préservation de la fertilité féminine

  2016cites this paper
• Préservation de la fertilité chez la femme en âge de procréer : indications et stratégies

  2016cites this paper
• Рак яичников в составе наследственных онкологических синдромов (обзор)

  year unknowncites this paper